Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-098325
Filing Date
2021-03-29
Accepted
2021-03-29 16:27:03
Documents
4
Effectiveness Date
2021-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 d165583ds8.htm S-8 50489
2 EX-5.1 d165583dex51.htm EX-5.1 7526
3 EX-23.1 d165583dex231.htm EX-23.1 1557
4 GRAPHIC g165583dsp1.jpg GRAPHIC 3741
  Complete submission text file 0001193125-21-098325.txt   65870
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254827 | Film No.: 21781979
SIC: 2834 Pharmaceutical Preparations